Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
Randomized, Observer-Blind, Placebo-Controlled, Phase 2/3 Study to Assess the Safety, Efficacy, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults 18 Years of Age or Older
INTERVENTIONAL
Inicio: 19 de nov de 2020
ID: NCT04636697
Completado
Fase 3
ClinicalTrials.gov
VALacyclovir In Delaying Antiretroviral Treatment Entry
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT00860977
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Open-Label Study of Vabomere(Meropenem-vaborbactam) Versus Best Available Therapy in Subjects With Selected Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
INTERVENTIONAL
Inicio: 1 de jul de 2014
ID: NCT02168946
Desconocido
Fase 2
ClinicalTrials.gov
Randomised Phase II Study to Assess the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schedules (rAd26-rAd5, rAd26-rAd26, rAd26-ChAdOx1 and rAd26-mRNA-1273).
INTERVENTIONAL
Inicio: 30 de jul de 2021
ID: NCT05027672
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis
INTERVENTIONAL
Inicio: 7 de nov de 2024
ID: NCT06632457
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection Who Are at High Risk for RSV-related Disease Progression
INTERVENTIONAL
Inicio: 17 de nov de 2021
ID: NCT04978337
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomized, Double-Blind (Sponsor Unblinded), Placebo-Controlled, Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH4524184 in HIV-1 Infected Treatment Naïve Adults
INTERVENTIONAL
Inicio: 7 de feb de 2024
ID: NCT06214052
Completado
ClinicalTrials.gov
Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients
OBSERVATIONAL
Inicio: 9 de abr de 2021
ID: NCT04944433
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in HIV-1 Infected Treatment-Naïve Participants
INTERVENTIONAL
Inicio: 8 de mar de 2023
ID: NCT05705349
Reclutando
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
INTERVENTIONAL
Inicio: 19 de ago de 2021
ID: NCT04849728
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rilematovir in Infants and Children (≥28 Days to ≤5 Years of Age) and Subsequently in Neonates (<28 Days of Age), Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
INTERVENTIONAL
Inicio: 6 de sept de 2021
ID: NCT04583280
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
INTERVENTIONAL
Inicio: 20 de nov de 2024
ID: NCT06532656
Desconocido
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific Immunotherapy With Racotumomab Plus Best Support Treatment Versus Best Support Treatment in Patients With Advanced Non-small Cell Lung Camcer.
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01460472
Completado
Fase 4
ClinicalTrials.gov
Bone and Body Comp: A Sub Study of the SECOND-LINE Study
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01513122
Completado
Fase 2
ClinicalTrials.gov
A 12-week Randomized, Patient and Investigator Blinded, Placebo-controlled, Parallel Group Study to Investigate the Efficacy of LIK066 in Obese Patients With Non-alcoholic Steatohepatitis (NASH)
INTERVENTIONAL
Inicio: 4 de oct de 2017
ID: NCT03205150
Completado
ClinicalTrials.gov
Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital. Missed Appointments Rates, Associated Factors, Generation and Validation of Predictive Models
OBSERVATIONAL
Inicio: 1 de mar de 2021
ID: NCT04736680
Completado
Fase 3
ClinicalTrials.gov
The ECLA PHRI COLCOVID Trial
INTERVENTIONAL
Inicio: 17 de abr de 2020
ID: NCT04328480
Completado
Fase 2
ClinicalTrials.gov
A Phase 2B Study of BMS-790052 in Combination With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who Are Null or Partial Responders to Prior Treatment With Peginterferon Alfa Plus Ribavirin Therapy
INTERVENTIONAL
Inicio: 1 de ago de 2010
ID: NCT01170962
Desconocido
ClinicalTrials.gov
Association of Symptoms, Clinical and Biochemical Characteristics in Post COVID-19 Syndrome: a Case-control Study
OBSERVATIONAL
Inicio: 16 de feb de 2023
ID: NCT05735782
Completado
Fase 4
ClinicalTrials.gov
IMPAACT 1077HS: HAART Standard Version of the Promoting Maternal and Infant Survival Everywhere (PROMISE) Study
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT00955968
Anterior
1
...
34
35
36
...
434
Siguiente
Filtros